Ascendis Pharma (spons. ADRs) Aktie
144,00
EUR
-10,00
EUR
-6,49
%
172,46
USD
-2,36
USD
-1,35
%
Werbung
Ascendis Pharma (spons. ADRs) Aktie Analyse
24.01.19 | Ascendis Pharma (spons. ADRs) Overweight | Cantor Fitzgerald | |
26.06.18 | Ascendis Pharma (spons. ADRs) Buy | Stifel, Nicolaus & Co., Inc. | |
26.09.16 | Ascendis Pharma (spons. ADRs) Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung